SANTA CLARA, Calif. -- Agilent Technologies Inc. (NYSE: A) today announced it has named Alacris Theranostics, a Berlin-based company active in the area of next-generation sequencing (NGS)-driven personalized medicine, as an Agilent Certified Service Provider for target enrichment.
Agilent certifies select laboratories that leverage the company's market-leading technologies to provide analysis services of the highest quality. Hands-on training from application scientists on Agilent's proven workflow solutions ensures that customers receive consistent data quality, reproducibility and reliability.
'We are honored to have Alacris Theranostics as part of the Agilent CSP program,' said Alessandro Borsatti, senior director of marketing for Agilent's Diagnostics and Genomics Group. 'Alacris is known for providing innovative approaches to cancer research and has used Agilent's NGS target enrichment solutions for several years. We look forward to supporting them as they expand their work.'
'Becoming an Agilent CSP for targeted enrichment services confirms the high standards adopted by Alacris,' said Dr. Bodo M.H. Lange, chief executive at Alacris. 'Certification will help to expand our growing reputation and assure our customers and collaborators in the sequencing and personalized medicine sector that we will deliver high-quality results.'
About Alacris Theranostics
Alacris Theranostics' mission is to exploit next-generation sequencing and other omics data through its predictive modeling system, ModCell, to facilitate drug development and personalized medicine in oncology and other complex diseases. This approach was originally developed at the Max Planck Institute for Molecular Genetics in Berlin and is exclusively licensed to Alacris Theranostics. Alacris provides professional expertise in next-generation sequencing, data analysis, and mathematical modeling for a wide variety of customers, including academic and pharma industry customers and within personalized medicine-oriented projects.
About Agilent Technologies
Agilent Technologies Inc. (NYSE: A), a global leader in life sciences, diagnostics, and applied chemical markets, is the premier laboratory partner for a better world. Agilent works with customers in more than 100 countries, providing instruments, software, services, and consumables for the entire laboratory workflow. Agilent generated revenues of $4.0 billion in fiscal 2014. The company employs about 12,000 people worldwide. Information about Agilent is available at www.agilent.com.